AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇦

Fulvestrant in South Africa

9 products registered with SAHPRA 9 active

Brand / ProductReg. No.HolderStatusExpires
FULVESTRANT SANDOZ56/21.12/0415Sandoz South Africa (Pty) Ltdactive2 Jul 2029
FUVISTRA56/21.12/0245Ranbaxy Pharmaceutical (Pty) Ltdactive25 Jun 2029
ACTIFULVE POWDER FOR SOLUTION FOR INJECTION AND ACTIFULVE DILUENT FOR SOLUTION FOR INJECTION56/21.12/0716Activo Health (Pty) Ltdactive7 May 2029
VESOTA56/26/0406.405Aurogen South Africa (Pty) Ltdactive3 Oct 2028
DESOFAL56/26/0405Aurogen South Africa (Pty) Ltdactive3 Oct 2028
FULVEDEX 250 mg/5 ml55/21.12/0531Juno Pharma SA (Pty) Ltdactive8 Nov 2027
FULDEXA55/21.12/0762Accord Healthcare (Pty) Ltdactive1 Nov 2027
FASLODEXA38/21.12/0656AstraZeneca Pharmaceuticals (Pty) Ltdactive1 Jan 1900
FREXIVO56/21.12/0606AstraZeneca Pharmaceuticals (Pty) Ltdactive1 Jan 1900

FulvestrantSAHPRA Registration Details

SAHPRA (South Africa) has 9 registered products containing Fulvestrant, of which 9 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Fulvestrant registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.